The funding opportunity announcement, PA-19-165, was recently posted for Administrative Supplement for Research on Sex/Gender Influences. This Funding Opportunity Announcement (FOA) requests applications for one year of funding for the fiscal year (FY) 2019 Administrative Supplements for Research on Sex/Gender Influences. This program is designed to provide supplemental funding to NIH-funded researchers to encourage the consideration of sex/gender factors in their ongoing research. The proposed research must address at least one of the five strategic goals of the new 2019-2023 Trans-NIH

This 2-year Postdoctoral Training Program in Behavioral Geriatrics develops independent investigators capable of conducting patient-oriented research to improve the quality of life and quality of care of older adults. The Program is co-led by Cary Reid, MD, PhD, Director of the Translational Research Institute on Pain in Later Life and Holly G. Prigerson, PhD, Director of the Center for Research on End-of-Life Care both based in the Department of Medicine, Division of Geriatrics and Palliative Medicine at Weill Cornell Medicine. Applications are accepted from both MD and PhD postdoctoral

PAR-19-136: End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R01 Clinical Trial Optional) Reissue of PA-18-137 The purpose of this funding opportunity announcement (FOA) is to foster research on the unique perspectives, needs, wishes, and decision-making processes of adolescents and young adults (AYA; defined by the World Health Organization and the Centers for Disease Control and Prevention as youth between 12–24 years of age) with serious, advanced illnesses; and research focused on specific end-of-life/palliative care (EOLPC) models that support

The notice NOT-AG-18-039 was recently posted for Alzheimer's-focused administrative supplements for NIH grants that are not focused on Alzheimer's disease https://grants.nih.gov/grants/guide/notice-files/NOT-AG-18-039.html Key aspects of NOT-AG-18-039 are as follows: Purpose is to expand existing awards that are not currently focused on Alzheimer’s disease and its related dementias (ADRD) to allow them to develop a focus on ADRD Active awards with project end dates in FY 2020 or later are eligible. The award may not be in terminal no cost extension or going into no cost extension in FY2019 One

NIH leadership from across the agency has been working diligently to identify areas of greatest opportunity for research to address the national opioid crisis. Several NIH HEAL (Helping to End Addiction Long-term SM) Initiative FOAs published in the NIH Guide on Dec 10 support "real world" assessment of health care strategies and clinical practices delivered across health care systems. Two of the published FOAs are soliciting pragmatic clinical trials that will leverage the NIH Collaboratory program infrastructure – via the Collaboratory Coordinating Center at Duke University. A brief

On November 29 th NINR’s Office of End of Life and Palliative Care will host an informational webinar on the new funding opportunity announcements: Strategies to Provide Culturally Tailored Palliative and End-of-Life Care for Seriously Ill American Indian and Alaska Native Individuals (R01 Clinical Trial Optional) PAR-19-057 Strategies to Provide Culturally Tailored Palliative and End-of-Life Care for Seriously Ill American Indian and Alaska Native Individuals (R21 Clinical Trial Optional) PAR-19-058 End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms (R01 Clinical Trial

The purpose of this funding opportunity announcement (FOA) is to encourage research that will improve and increase the use of evidence-based interventions in end-of-life and palliative care (EOLPC) for American Indian/Alaska Native (AI/AN) individuals with advanced illness and their families and communities. Research objectives include, but are not limited to, those that address: Determination of the unique perceptions of EOLPC in seriously ill AI/AN individuals within and across tribes. The design, testing, and evaluation of tools/strategies to assess and care for those with advanced

NINR is interested in studies examining the multi-dimensional foundations, experiences and management of advanced signs and symptoms specific to individuals with advanced serious illness within the period of end of life (prognosis of 12 months or less) including, but not limited to: Pain Fatigue Respiratory signs and symptoms, including dyspnea, audible secretions/congestion, cough, respirations with mandibular movement, hemoptysis, etc. Cardiovascular signs and symptoms, including edema, cyanosis, weakness, etc. Gastrointestinal or digestive signs symptoms, including anorexia, cachexia

The National Palliative Care Research Center (NPCRC) is soliciting applications for Pilot/Exploratory Project Grants (PEP) and Junior Faculty Career Development Awards (CDA). Please note that this will be the last year of the Pilot/Exploratory Project Grant Program due to NPCRC’s expansion of CDA funding opportunities in 2019. These RFAs are limited to applications that focus on palliative care research projects for seriously ill patients and their families in one or more of the three specific areas: Exploring the relationship of pain and other distressing symptoms to quality and quantity of

The goal of this funding initiative is to support patient- and caregiver-centered, comparative clinical effectiveness research to generate important findings that will aid decision making about symptom management in advanced illness. PCORI seeks to fund multiple high quality clinical studies that compare the effectiveness of evidence-based treatments for relief of common symptoms experienced by patients with serious, advanced illness. The mission of the PCORI is to improve the quality and relevance of evidence available to help patients, caregivers, clinicians, employers, insurers, and policy